The eff ect of two Iranian viper snake; vipera albicornuta (zanjani) and vipera latifi i (lattifi i) venoms on the viability of rat bone marrow mesenchymal stem cells in vitro and in vivo

Iranian Journal of Veterinary Science and Technology

مقاله 5، دوره 11، شماره 1 - شماره پیاپی 20، اسفند 2019، صفحه 27-33   

نوع مقاله: Research Articles

شناسه دیجیتال (DOI): 10.22067/veterinary.v1i11.76565

نویسندگان

Fatemeh Salami^{* 1}؛ Fatemeh Younesi Soltani²؛ Amin Tavassoli²؛ Behrooz Fathi²

¹School of Veterinary MedicineFerdowsi University of Mashhad

²Faculty of Veterinary MedicineFerdowsi University of Mashhad

چکیده

Snake venom is a complex mixture of different compounds which have potential pharmacological properties and may affect mesenchymal stem cells (MSCs). In this study we investigate the effects of two Iranian vipers; vipera albicornuta and vipera latifii crude venoms on the viability of MScs in vivo and in vitro. The cells in in vitro tests were treated with different concentrations (1, 2, 3, 4 and 5 μg/100μl) of mentioned venoms for 24, 48 and 72 hours.The cells in in vivo experiment only were treated with v. Latifii venom at the concentration of 1μg/100μl and time intervals as in vitro tests. The cell viability in in vitro experiment was assessed using MTT assay. The results of in vitro experiments showed that maximum cell viability was observed at concentrations of 1 and 2 μg/100μl of v. albicornuta and v. latifi ivenoms aft er 48 and 72 hours, respectively. The results of in vivo experiment showed that the cells treated with v. Latifii venom for 72 hours in situ have the highest proliferation rate after passages three, four and five in comparison to control. The results of this study showed that the v. albicornuta and v. latifi i venoms can affect the confluence and viability of the MSCs.

کلیدواژه‌ها

Mesenchymal Stem Cells؛ venom؛ Viper snake؛ Cell culture؛ Bone marrow

مراجع

1. Solchaga LA, Lazarus HM. Th erapeutic Potential of Mesenchymal

Stem Cells in Hematopoietic Stem Cell Transplantation.

Allogeneic Stem Cell Transplant. 2010;477–90.

2. Wexler SA, Donaldson C, Denning-Kendall P, Rice C, Bradley

B, Hows JM. Adult bone marrow is a rich source of human

mesenchymal “stem” cells but umbilical cord and mobilized

adult blood are not. Br J Haematol. 2003;121(2):368–74.

3. Friedenstein A, Chailakhjan R, Lalykina K. the Development

of Fibroblast Colonies in Monolayer Cultures of Guinea. Cell

Prolif. 1970;3(4):393–403.

4. da Silva Meirelles L, Caplan AI, Nardi NB. In Search of the

In Vivo Identity of Mesenchymal Stem Cells. Stem Cells.

2008;26(9):2287–99.

5. E. Hanson S, L. Th ibeault S, Hematti P. Clinical Applications

of Mesenchymal Stem Cells in Laryngotracheal Reconstruction.

Curr Stem Cell Res Th er. 2010;5(3):268–72.

6. Trounson A, Th akar RG, Lomax G, Gibbons D. Clinical trials

for stem cell therapies. Vol. 9, BMC Medicine. 2011. p. 52.

7. Udalamaththa VL, Jayasinghe CD,

Udagama PV. Potential role of herbal

remedies in stem cell therapy: proliferation

and diff erentiation of human

mesenchymal stromal cells. Stem Cell

Res Th er. 2016;7(1):1–8.

8. Mackessy SP. Th rombin-like enzymes

in snake venoms. Toxins Hemost

From Bench to Bedside. 2011;519–57.

9. Tu AT. Snake venoms: general background

and composition. Venoms

Chem Mol Biol. 1988;1–19.

10. Siigur E, Aaspõllu A, Siigur J. Sequence

diversity of Vipera lebetina

snake venom gland serine proteinase

homologs - Result of alternative-splicing

or genome alteration. Gene.

2001;263(1–2):199–203.

11. Kessler P, Menez A, Michalet S,

Gilquin B, Servent D, Tzartos S, et al.

Relative Spatial Position of a Snake

Neurotoxin and the Reduced Disulfi

de Bond α(Cys 192 -Cys 193 )

at the αγ Interface of the Nicotinic

Acetylcholine Receptor. J Biol Chem.

2002;275(33):25608–15.

12. Harvey AL. Natural products in drug

discovery. Drug Discovery Today.

Drug Discov Today. 2015;13:894–901.

13. Chan WY, Xia L, Chan YS, Cheung

RCF, Wong JH, Ng TB. Snake venom

toxins: toxicity and medicinal applications.

Appl Microbiol Biotechnol.

2016;100(14):6165–81.

14. Lu Z, Lei D, Jiang T, Yang L, Zheng

L, Disease JZ-C death &, et al. Nerve

growth factor from Chinese cobra

venom stimulates chondrogenic differentiation

of mesenchymal stem

cells. NatureCom. 2017;8(5).

15. Li X, Chen M, Lei D, Yang B, Liao G-S,

Shu Y-Y, et al. Bioactivities of nerve

growth factor from Chinese cobra

venom. J Nat Toxins. 1999;8(3):359–

62.

16. Asaoka Y, Yoshida K, Sasaki Y,

Nishizuka Y. Potential role of phospholipase

A2 in HL-60 cell diff erentiation

to macrophages induced by

protein kinase C activation. Proc Natl

Acad Sci U S A. 1993;90(11):4917–21.

17. Li W, Yeo LS, Vidal C, McCorquodale

T, Herrmann M, Fatkin D, et al. Decreased

bone formation and osteopenia

in lamin A/C-defi cient mice.

Vanacker J-M, editor. PLoS One. 2011

Apr 25;6(4):e19313.

18. Gasparotto VPO, Landim-Alvarenga

FC, Oliveira ALR, Simões GF, Lima-

Neto JF, Barraviera B, et al. A new

fi brin sealant as a three-dimensional

scaff old candidate for mesenchymal

stem cells. Stem Cell Res Th er.

2014;5(3):78.

19. Kouchesfahani HM, Nabiuni M, Parivar

K, Ebrahimi S. Eff ect of honey bee

venom on diff erentiation of cholinergic

neurons. J Venom Res. 2010;1:29–

36.

20. Chen HH, Decot V, Ouyang JP, Stoltz

JF, Bensoussan D, De Isla NG. In vitro

initial expansion of mesenchymal

stem cells is infl uenced by the culture

parameters used in the isolation process.

Biomed Mater Eng. 2009;19(4–

5):301–9.

21. Sun Y, Zhang L, Wang H, Zhu H,

Wang H, Gao Y, et al. Soluble Tumor

Necrosis Factor Receptor 1 Released

by Skin-Derived Mesenchymal Stem

Cells Is Critical for Inhibiting Th 17

Cell Diff erentiation. Stem Cells Transl

Med. 2016 Mar;5(3):301–13.

22. Collins C, Liem M, Ravichandran

KS, Atkin-Smith GK, Mathivanan S,

Goodall KJ, et al. A novel mechanism

of generating extracellular vesicles

during apoptosis via a beads-on-astring

membrane structure. Nat Commun.

2015;6(1).

23. Valadi H, Ekström K, Bossios A,

Sjöstrand M, Lee JJ, Lötvall JO. Exosome-

mediated transfer of mRNAs

and microRNAs is a novel mechanism

of genetic exchange between cells. Nat

Cell Biol. 2007;9(6):654–9.

24. Pallinger É, Laszlo V, Pasztoi M, Nagy

G, Pal Z, Kittel Á, et al. Membrane

vesicles, current state-of-the-art:

emerging role of extracellular vesicles.

Cell Mol Life Sci. 2011;68(16):2667–

88.

25. Vlassov A V., Magdaleno S, Setterquist

R, Conrad R. Exosomes: Current

knowledge of their composition,

biological functions, and diagnostic

and therapeutic potentials. Vol. 1820,

Biochimica et Biophysica Acta - General

Subjects. 2012. p. 940–8.

26. Crescitelli R, Lässer C, Szabo TG, Kittel

A, Eldh M, Dianzani I, et al. Distinct

RNA profi les in subpopulations

of extracellular vesicles: Apoptotic

bodies, microvesicles and exosomes. J

Extracell Vesicles. 2013;2(1):20677.

27. Trummal K, Tõnismägi K, Paalme

V, Järvekülg L, Siigur J, Siigur E.

Molecular diversity of snake venom

nerve growth factors. Toxicon.

2011;58(4):363–8.

28. Nakashima S, Kitamoto K, Arioka M.

Th e catalytic activity, but not receptor

binding, of sPLA2s plays a critical role

for neurite outgrowth induction in

PC12 cells. Brain Res. 2004;1015(1–

2):207–11.

29. Mora R, Valverde B, Diaz C, Lomonte

B, Gutierrez JM. A Lys49 phospholipase

A2 homologue from Bothrops

asper snake venom induces proliferation,

apoptosis and necrosis in a

lymphoblastoid cell line. Toxicon.

2005;45(5):651–60.

30. J.B. H, T. S-D. Secreted phospholipases

A2 of snake venoms: Eff ects on

the peripheral neuromuscular system

with comments on the role of phospholipases

A2 in disorders of the CNS

and their uses in industry. Toxins (Basel).

2013;5(12):2533–71.